Ralpancizumab

Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.
Read more
€0.00 (tax incl.)
Reference:
HY-P99816
Product Details
HY-P99816

Data sheet

Size
Multiple sizes
Reactivity
Ser/Thr Protease
Application
Metabolism-protein/nucleotide metabolism
CAS
1407495-04-8

Menu

Settings